首页> 外文期刊>Brain, Behavior, and Immunity >Vitamin D receptor (VDR) gene SNPs influence VDR expression and modulate protection from multiple sclerosis in HLA-DRB1*15-positive individuals.
【24h】

Vitamin D receptor (VDR) gene SNPs influence VDR expression and modulate protection from multiple sclerosis in HLA-DRB1*15-positive individuals.

机译:维生素D受体(VDR)基因SNP影响HDR-DRB1 * 15阳性个体的VDR表达并调节其免受多发性硬化的保护。

获取原文
获取原文并翻译 | 示例
           

摘要

Multiple sclerosis (MS) is an autoimmune disease with a multifactorial etiology. The HLA-DRB1*15 allele, is the main genetic risk factor for MS in Caucasians; recent findings showed that the transcription of this molecule is regulated by the vitamin D/vitamin D receptor (VDR) complex. We analyzed SNPs within the VDR gene in association with the HLA-DRB1 locus in 641 MS patients diagnosed according to McDonald criteria and 558 age- and sex-matched healthy controls, to verify possible correlations between the vitamin D/VDR complex, HLA-DRB1, and susceptibility to MS. Results confirmed that HLA-DRB1*15 is a strong predisposing allele (p<1x10(-7); OR: 3.04; 95% CI: 2.02-4.60) for MS. Cosegregation analyses of VDR SNPs with HLA-DRB1*15 indicated a reduction of risk for MS given by the presence of the -DRB1*15-rs731236 T VDR haplotype (p=9.5x10(-5); OR: 2.52; 95% CI: 1.56-4.06) and, conversely, an augmented risk for disease associated with the -DRB1*15-rs731236 C VDR haplotype. Analyses performed on HLA-DRB1*15-positive MS patients and HC alone confirmed the protective role of rs731236 TT VDR genotype (p(y)=0.004; OR: 0.53; 95% CI: 0.33-0.83); notably, FACS, PCR, and confocal microscopy analyses showed that rs731236 TT genotype is associated with an augmented VDR expression in MBP-stimulated PBMC from patients. In conclusion, rs731236 TT VDR genotype modulates VDR expression and confers protection against MS in HLA-DRB1*15-positive individuals. Results herein offer a model justifying the interaction between the major genetic (HLA-DRB*15) and environmental (vitamin D) factors associated with MS onset.
机译:多发性硬化症(MS)是一种具有多种病因的自身免疫性疾病。 HLA-DRB1 * 15等位基因是高加索人MS的主要遗传危险因素。最近的发现表明该分子的转录受维生素D /维生素D受体(VDR)复合物调节。我们分析了根据麦当劳标准诊断的641名MS患者和558名年龄和性别相匹配的健康对照者的VDR基因中的单核苷酸多态性与HLA-DRB1基因座的关联,以验证维生素D / VDR复合物HLA-DRB1之间的可能相关性以及对MS的敏感性。结果证实HLA-DRB1 * 15是MS的强诱因等位基因(p <1x10(-7); OR:3.04; 95%CI:2.02-4.60)。对具有HLA-DRB1 * 15的VDR SNP进行的聚类分析表明,通过存在-DRB1 * 15-rs731236 T VDR单倍型(p = 9.5x10(-5); OR:2.52; 95%CI :1.56-4.06),相反,与-DRB1 * 15-rs731236 C VDR单倍型相关的疾病的风险增加。对HLA-DRB1 * 15阳性MS患者和仅HC的分析证实了rs731236 TT VDR基因型的保护作用(p(y)= 0.004; OR:0.53; 95%CI:0.33-0.83);值得注意的是,FACS,PCR和共聚焦显微镜分析表明,rs731236 TT基因型与患者MBP刺激的PBMC中VDR表达的增加有关。总之,在HLA-DRB1 * 15阳性个体中,rs731236 TT VDR基因型调节VDR表达并赋予针对MS的保护。本文的结果提供了证明与MS发作相关的主要遗传(HLA-DRB * 15)和环境(维生素D)因子之间相互作用的模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号